The Effect of Steroid Intervention before Vitrectomy for Rhegmatogenous Retinal Detachment Associated with Choroidal Detachment: A Meta-Analysis and Systematic Review

References

• Yu Y, An M, Mo B, Yang Z, Liu W. Risk factors for choroidal detachment following rhegmatogenous retinal detachment in a Chinese population. BMC Ophthalmol. 2016;16(1):140. doi: 10.1186/s12886-016-0319-9.
   PubMedGoogle Scholar
• Gottlieb F. Combined choroidal and retinal detachment. Arch Ophthalmol. 1972;88(5):481–486. doi: 10.1001/archopht.1972.01000030483003.
   PubMedGoogle Scholar
• Li Z, Li Y, Huang X, Cai XY, Chen X, Li S, Huang Y, Lu L. Quantitative analysis of rhegmatogenous retinal detachment associated with choroidal detachment in Chinese using UBM. Retina. 2012;32(10):2020–2025. doi: 10.1097/IAE.0b013e3182561f7c.
   PubMed Web of Science ®Google Scholar
• Sharma T, Challa JK, Ravishankar KV, Murugesan R. Scleral buckling for retinal detachment: predictors for anatomic failure. Retina. 1994;14(4):338–343. doi: 10.1097/00006982-199414040-00008.
   PubMed Web of Science ®Google Scholar
• Iyer SSR, Regan KA, Burnham JM, Chen CJ. Surgical management of diabetic tractional retinal detachments. Surv Ophthalmol. 2019;64(6):780–809. doi: 10.1016/j.survophthal.2019.04.008.
   PubMed Web of Science ®Google Scholar
• Jarrett WH. Rhematogenous retinal detachment complicated by severe intraocular inflammation, hypotony, and choroidal detachment. Trans Am Ophthalmol Soc. 1981;79:664–683.
   PubMedGoogle Scholar
• Luo S, Xu H, Gong X, Shen J, Chen X, Wu Z. The complement C3a-C3aR and C5a-C5aR pathways promote viability and inflammation of human retinal pigment epithelium cells by targeting NF-κB signaling. Exp Ther Med. 2002;24(2):493. doi: 10.3892/etm.2022.11420.
   Google Scholar
• Adelman RA, Parnes AJ, Sipperley JO, Ducournau D, European Vitreo-Retinal Society (EVRS) Retinal Detachment Study Group. Strategy for the management of complex retinal detachments: the European Vitreo-Retinal Society Retinal Detachment Study Report 2. Ophthalmology. 2013;120(9):1809–1813. doi: 10.1016/j.ophtha.2013.01.056.
   PubMed Web of Science ®Google Scholar
• Moysidis SN, Thanos A, Vavvas DG. Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside. Mediators Inflamm. 2012;2012:815937. doi: 10.1155/2012/815937.
   PubMed Web of Science ®Google Scholar
• Moher D, Cook DJ, Jadad AR, Tugwell P, Moher M, Jones A, Pham B, Klassen TP. Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses. Health Technol Assess. 1999;3(12):i–iv, 1–98.
   PubMedGoogle Scholar
• Cheema RA, Peyman GA, Fang T, Jones A, Lukaris AD, Lim K. Triamcinolone acetonide as an adjuvant in the surgical treatment of retinal detachment with proliferative vitreoretinopathy. Ophthalmic Surg Lasers Imaging. 2007;38(5):365–370. doi: 10.3928/15428877-20070901-02.
   PubMedGoogle Scholar
• Chen W, Chen H, Hou P, Fok A, Hu Y, Lam DSC. Midterm results of low-dose intravitreal triamcinolone as adjunctive treatment for proliferative vitreoretinopathy. Retina. 2011;31(6):1137–1142. doi: 10.1097/IAE.0b013e3181fe5427.
   PubMed Web of Science ®Google Scholar
• Sharma T, Gopal L, Badrinath SS. Primary vitrectomy for rhegmatogenous retinal detachment associated with choroidal detachment. Ophthalmology. 1998;105(12):2282–2285. doi: 10.1016/S0161-6420(98)91230-1.
   PubMed Web of Science ®Google Scholar
• Sharma T, Gopal L, Reddy RK, Kasinathan N, Shah NA, Sulochana KN, Miriam KC, Arvind K, Ramakrishnan S, Sukumar B. Primary vitrectomy for combined rhegmatogenous retinal detachment and choroidal detachment with or without oral corticosteroids: a pilot study. Retina. 2005;25(2):152–157. doi: 10.1097/00006982-200502000-00006.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634. doi: 10.1136/bmj.315.7109.629.
   PubMed Web of Science ®Google Scholar
• Denwattana A, Prakhunhungsit S, Thoongsuwan S, Rodanant N, Phasukkijwatana N. Surgical outcomes of preoperative steroid for rhegmatogenous retinal detachment with associated choroidal detachment. Eye. 2018;32(3):602–607. doi: 10.1038/eye.2017.262.
   PubMed Web of Science ®Google Scholar
• Wei Y, Wang N, Chen F, Wang H, Bi C, Zu Z, Yang X. Vitrectomy combined with periocular/intravitreal injection of steroids for rhegmatogenous retinal detachment associated with choroidal detachment. Retina. 2014;34(1):136–141. doi: 10.1097/IAE.0b013e3182923463.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhang R, He J, Xu C, Li Z. Preoperative steroid use in rhegmatogenous retinal detachment associated with choroidal detachment after 23-gauge vitrectomy. J Ophthalmol. 2020;2020:6707239. doi: 10.1155/2020/6707239.
   PubMed Web of Science ®Google Scholar
• Yu Y, Yue Y, Tong N, Zheng P, Liu W, An M. Anatomic outcomes and prognostic factors of vitrectomy in patients with primary rhegmatogenous retinal detachment associated with choroidal detachment. Curr Eye Res. 2019;44(3):329–333. doi: 10.1080/02713683.2018.1540705.
   PubMed Web of Science ®Google Scholar
• Wei Y, Zhou R, Wang X, Chen X, Chen H. The effect of single periocular injection of methylprednisolone and drainage of suprachoroidal fluid in the treatment of rhegmatogenous retinal detachment combined with choroidal detachment. Eye. 2019;33(9):1387–1392. doi: 10.1038/s41433-019-0420-4.
   PubMed Web of Science ®Google Scholar
• Dai Y, Wu Z, Sheng H, Zhang Z, Yu M, Zhang Q. Identification of inflammatory mediators in patients with rhegmatogenous retinal detachment associated with choroidal detachment. Mol Vis. 2015;21:417–427.
   PubMed Web of Science ®Google Scholar
• Nagpal M, Chaudhary P, Wachasundar S, Eltayib A, Raihan A. Management of recurrent rhegmatogenous retinal detachment. Indian J Ophthalmol. 2018;66(12):1763–1771. doi: 10.4103/ijo.IJO_1212_18.
   PubMed Web of Science ®Google Scholar
• Howard JE, Harvey AM, Carey RA, Winkenwerder WL. Effects of pituitary adrenocorticotropic hormone (ACTH) on the hypersensitive state. J Am Med Assoc. 1950;144(16):1347–1349. doi: 10.1001/jama.1950.02920160021004.
   PubMed Web of Science ®Google Scholar
• Mańkowska A, Rejdak R, Oleszczuk A, Kiczyńska M, Łekawa A, Choragiewicz T, Zagórski Z. Decrease of the postoperative inflammatory reaction during pars plana vitrectomy (PPV) after administration of triamcinolone acetonide. Klin Oczna. 2008;110(4–6):151–154.
   PubMedGoogle Scholar
• Shen L, You Y, Sun S, Chen Y, Qu J, Cheng L. Intraocular and systemic pharmacokinetics of triamcinolone acetonide after a single 40-mg posterior subtenon application. Ophthalmology. 2010;117(12):2365–2371. doi: 10.1016/j.ophtha.2010.03.033.
   PubMed Web of Science ®Google Scholar
• Shen L, Mao J, Sun S, Dong Y, Chen Y, Cheng L. Perioperative pharmacological management of choroidal detachment associated with rhegmatogenous retinal detachment. Acta Ophthalmol. 2016;94(4):391–396.
   PubMed Web of Science ®Google Scholar
• Loo A, Fitt AW, Ramchandani M, Kirkby GR. Pars plana vitrectomy with silicone oil in the management of combined rhegmatogenous retinal and choroidal detachment. Eye. 2001;15(Pt 5):612–615. doi: 10.1038/eye.2001.195.
   PubMedGoogle Scholar
• Weijtens O, van der Sluijs FA, Schoemaker RC, Lentjes EG, Cohen AF, Romijn FP, van Meurs JC. Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection. Am J Ophthalmol. 1997;123(3):358–363. doi: 10.1016/s0002-9394(14)70131-x.
   PubMed Web of Science ®Google Scholar
• Weijtens O, Feron EJ, Schoemaker RC, Cohen AF, Lentjes EG, Romijn FP, van Meurs JC. High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection. Am J Ophthalmol. 1999;128(2):192–197. doi: 10.1016/s0002-9394(99)00129-4.
   PubMed Web of Science ®Google Scholar
• Furino C, Micelli Ferrari T, Boscia F, Cardascia N, Recchimurzo N, Sborgia C. Triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy. Retina. 2003;23(6):771–776. doi: 10.1097/00006982-200312000-00004.
   PubMed Web of Science ®Google Scholar
• Sakamoto T, Ishibashi T. Visualizing vitreous in vitrectomy by triamcinolone. Graefes Arch Clin Exp Ophthalmol. 2009;247(9):1153–1163. doi: 10.1007/s00417-009-1118-2.
   PubMed Web of Science ®Google Scholar
• Sonoda KH, Enaida H, Ueno A, Nakamura T, Kawano YI, Kubota T, Sakamoto T, Ishibashi T. Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study. Br J Ophthalmol. 2003;87(8):1010–1014. doi: 10.1136/bjo.87.8.1010.
   PubMed Web of Science ®Google Scholar